Trial Profile
An Observational, Cohort study comparing the efficacy of ticagrelor or prasugrel versus clopidogrel for Acute Coronary Syndrome in patients with Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2017
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 19 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management